Core I - The CFAR International Core facilitates collaborative HIV/AIDS research activities involving CFAR members and their international colleagues by providing logistical, administrative and technical support;strategic planning;and seed funding.
The specific AIMS of the CFAR International Core are as follows: 1. Enhance existing collaborations and facilitate new ones between the CFAR research community and investigators working in resource-limited settings. 2. Facilitate the development of preliminary data in resource-limited settings to support more extensive externally funded research projects and programs. 3. Create opportunities for international researchers based in resource-limited settings to gain first-rate technical skills and establish professional connections with CFAR investigators. The International Core provides centralized administrative and logistical support to CFAR members to reduce delays in launching international research projects. Our International Pilot grants provide seed funds to foreign investigators in collaboration with CFAR members for research leading to more extensive investigations. Our Visiting Researchers and Travel grant programs facilitate the exchange of scholars between UCSD and institutions in our target countries. We organize and host an Annual Research Day to showcase international research undertaken by CFAR members and their foreign collaborators. Our Research Day increases the visibility of our CFAR's international research and helps disseminate research that is timely and topical to the San Diego HIV/AIDS research community.

Public Health Relevance

Two-thirds of the HIV pandemic is centered in Africa, 15% in Asia, and <5% in North America. The UCSD CFAR International Core supports research and training opportunities for foreign researchers in 7 middle and low-income countries to improve their capacity to respond to their local HIV epidemics, and to generate preliminary data for publications and proposals in partnership with CFAR collaborators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI036214-20
Application #
8648961
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
20
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Burlacu, Ruxandra; Umlauf, Anya; Luca, Anca et al. (2018) Sex-based differences in neurocognitive functioning in HIV-infected young adults. AIDS 32:217-225
Cachay, Edward R; Agmas, Wollelaw; Christopher Mathews, Wm (2018) Disparities in the Clinical Evolution of Anal Neoplasia in an HIV-Infected Cohort. J Racial Ethn Health Disparities 5:209-212
Pines, H A; Strathdee, S A; Hendrix, C W et al. (2018) Oral and vaginal HIV pre-exposure prophylaxis product attribute preferences among female sex workers in the Mexico-US border region. Int J STD AIDS :956462418793038
Jain, Prashant; Boso, Guney; Langer, Simon et al. (2018) Large-Scale Arrayed Analysis of Protein Degradation Reveals Cellular Targets for HIV-1 Vpu. Cell Rep 22:2493-2503
Pines, Heather A; Semple, Shirley J; Strathdee, Steffanie A et al. (2018) Vaginal washing and lubrication among female sex workers in the Mexico-US border region: implications for the development of vaginal PrEP for HIV prevention. BMC Public Health 18:1009
Sun, Alexander C; Alvarez-Fontecilla, Enrique; Venkatesh, A G et al. (2018) High-Density Redox Amplified Coulostatic Discharge-Based Biosensor Array. IEEE J Solid-State Circuits 53:2054-2064
Saag, Michael S; Benson, Constance A; Gandhi, Rajesh T et al. (2018) Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel. JAMA 320:379-396
Borquez, Annick; Beletsky, Leo; Nosyk, Bohdan et al. (2018) The effect of public health-oriented drug law reform on HIV incidence in people who inject drugs in Tijuana, Mexico: an epidemic modelling study. Lancet Public Health 3:e429-e437
Fraser, Hannah; Martin, Natasha K; Brummer-Korvenkontio, Henrikki et al. (2018) Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe. J Hepatol 68:402-411
Garfein, Richard S; Liu, Lin; Cuevas-Mota, Jazmine et al. (2018) Tuberculosis Treatment Monitoring by Video Directly Observed Therapy in 5 Health Districts, California, USA. Emerg Infect Dis 24:1806-1815

Showing the most recent 10 out of 921 publications